Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration. (March 2016)
- Record Type:
- Journal Article
- Title:
- Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration. (March 2016)
- Main Title:
- Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration
- Authors:
- Ellefsen, Kayla N.
Concheiro, Marta
Pirard, Sandrine
Gorelick, David A.
Huestis, Marilyn A. - Abstract:
- Highlights: Oral fluid (OF) pharmacokinetic data after intravenous cocaine are presented. Oral-Eze and StatSure OF collection device performance was evaluated. Oral-Eze had significantly longer cocaine OF T 1/2 (1.3 h) than StatSure (0.89 h). Oral-Eze and StatSure devices were effective in monitoring cocaine and BE in OF. Cocaine and BE confirmatory cutoffs can be selected to meet drug testing needs. Abstract: Limited oral fluid (OF) pharmacokinetic data collected with commercially available collection devices after controlled cocaine administration hinder OF result interpretations. Ten cocaine-using adults provided OF, collected with Oral-Eze ® (OE) and StatSure Saliva Sampler™ (SS) devices, an hour prior to and up to 69 h after 25 mg intravenous (IV) cocaine administration. Cocaine and benzoylecgonine (BE) were quantified by a validated 2D-GC-MS method. Large inter-subject variability was observed. Cocaine was detected in OF in the first 0.17 h sample after IV administration, with much more rapid elimination than BE. OE observed C max median (range) concentrations were 932 (394–1574) μg/L for cocaine and 248 (96.9–953) μg/L for BE. SS observed cocaine and BE C max median (range) concentrations trended lower at 732 (83.3–1892) μg/L and 360 (77.2–836) μg/L, respectively. OE and SS cocaine OF detection times were 12.5 and 6.5 h and for BE 30.5 and 28.0 h, respectively at 1 μg/L. There were no significant pharmacokinetic differences between OE and SS OF collection devices,Highlights: Oral fluid (OF) pharmacokinetic data after intravenous cocaine are presented. Oral-Eze and StatSure OF collection device performance was evaluated. Oral-Eze had significantly longer cocaine OF T 1/2 (1.3 h) than StatSure (0.89 h). Oral-Eze and StatSure devices were effective in monitoring cocaine and BE in OF. Cocaine and BE confirmatory cutoffs can be selected to meet drug testing needs. Abstract: Limited oral fluid (OF) pharmacokinetic data collected with commercially available collection devices after controlled cocaine administration hinder OF result interpretations. Ten cocaine-using adults provided OF, collected with Oral-Eze ® (OE) and StatSure Saliva Sampler™ (SS) devices, an hour prior to and up to 69 h after 25 mg intravenous (IV) cocaine administration. Cocaine and benzoylecgonine (BE) were quantified by a validated 2D-GC-MS method. Large inter-subject variability was observed. Cocaine was detected in OF in the first 0.17 h sample after IV administration, with much more rapid elimination than BE. OE observed C max median (range) concentrations were 932 (394–1574) μg/L for cocaine and 248 (96.9–953) μg/L for BE. SS observed cocaine and BE C max median (range) concentrations trended lower at 732 (83.3–1892) μg/L and 360 (77.2–836) μg/L, respectively. OE and SS cocaine OF detection times were 12.5 and 6.5 h and for BE 30.5 and 28.0 h, respectively at 1 μg/L. There were no significant pharmacokinetic differences between OE and SS OF collection devices, except cocaine half-life was significantly shorter in SS OF specimens. This difference could be attributed to differences in stabilizing buffers present in OF collection devices, which may affect cocaine stability in OF specimens, or decreased recovery from collection pads. Both OE and SS OF collection devices were effective in monitoring cocaine and metabolite concentrations with similar detection windows. Furthermore, we demonstrated that different confirmatory OF cutoffs can be selected to produce shorter or longer cocaine and metabolite detection windows to address specific needs of clinical and forensic drug testing programs. … (more)
- Is Part Of:
- Forensic science international. Volume 260(2016)
- Journal:
- Forensic science international
- Issue:
- Volume 260(2016)
- Issue Display:
- Volume 260, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 260
- Issue:
- 2016
- Issue Sort Value:
- 2016-0260-2016-0000
- Page Start:
- 95
- Page End:
- 101
- Publication Date:
- 2016-03
- Subjects:
- Cocaine -- Benzoylecgonine -- Oral Fluid -- Oral-Eze® -- Pharmacokinetics -- StatSure Saliva Sampler™
Medical jurisprudence -- Periodicals
Chemistry, Forensic -- Periodicals
Forensic Medicine -- Periodicals
Médecine légale -- Périodiques
Chimie légale -- Périodiques
Gerechtelijke geneeskunde
Gerechtelijke chemie
Gerechtelijke psychiatrie
Chemistry, Forensic
Medical jurisprudence
Electronic journals
Periodicals
Electronic journals
614.1 - Journal URLs:
- http://www.clinicalkey.com.au/dura/browse/journalIssue/03790738 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/03790738 ↗
http://www.sciencedirect.com/science/journal/03790738 ↗
http://infotrac.galegroup.com/itw/infomark/1/1/1/purl=rc18_EAIM_0__jn+%22Forensic+Science+International%22?sw_aep=stand ↗
http://www.elsevier.com/homepage/elecserv.htt ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.forsciint.2016.01.013 ↗
- Languages:
- English
- ISSNs:
- 0379-0738
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3987.764000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2090.xml